ATF4 Gene

ATF4 Gene

Introduction

Pathway Diagram

```mermaid
flowchart TD
ATF4["ATF4<br/>Transcription Factor"]

%% ER Stress and UPR Pathway
ER_Stress["ER Stress<br/>Response"]
XBP1["XBP1<br/>ER Stress Regulator"]
HSPA5["HSPA5<br/>BiP/GRP78"]
DDIT3["DDIT3<br/>CHOP"]
PPP1R15A["PPP1R15A<br/>GADD34"]

%% Mitochondrial Quality Control
Mitophagy["Mitophagy<br/>Process"]

%% Inflammatory Response
IL6["IL6<br/>Pro-inflammatory"]
CXCL2["CXCL2<br/>Chemokine"]
IL12B["IL12B<br/>Cytokine"]
CXCL1["CXCL1<br/>Chemokine"]
IL23A["IL23A<br/>Pro-inflammatory"]

%% Blood-Brain Barrier
CLDN5["CLDN5<br/>Claudin-5"]
OCLN["OCLN<br/>Occludin"]

%% Disease Outcomes
ALS["Amyotrophic<br/>Lateral Sclerosis"]
MS["Multiple<br/>Sclerosis"]
Aging["Aging<br/>Process"]

%% Connections
ATF4 -->|"activates"| ER_Stress
ATF4 -->|"activates"| XBP1
ATF4 -->|"activates"| HSPA5
ATF4 -->|"activates"| DDIT3
ATF4 -->|"activates"| PPP1R15A
ATF4 -->|"regulates"| Mitophagy

IL6 -->|"targets"| ATF4
CXCL2 -->|"targets"| ATF4

ATF4 -->|"targets"| IL12B
ATF4 -->|"targets"| CXCL1
ATF4 -->|"targets"| IL23A
ATF4 -->|"targets"| CLDN5
ATF4 -->|"targets"| OCLN

ATF4 -->|"regulates"| ALS
ATF4 -->|"regulates"| MS
ATF4 -->|"regulates"| Aging

DDIT3 -->|"promotes"| ALS
ER_Stress -->|"contributes"| MS

%% Styling
style ATF4 fill:#006494
style Mitophagy fill:#1b5e20
style HSPA5 fill:#1b5e20
style XBP1 fill:#4a1a6

ATF4 Gene

Introduction

Pathway Diagram

Atf4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
title: ATF4 Gene
<div class="infobox .infobox-gene">
<table>
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.1em;">ATF4</th></tr>
<tr><td><b>Full Name</b></td><td>Activating Transcription Factor 4</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>22q13.1</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[466](https://www.ncbi.nlm.nih.gov/gene/466)</td></tr>
<tr><td><b>OMIM</b></td><td>[604064](https://www.omim.org/entry/604064)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>[ENSG00000128272](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000128272)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9Y2K2](https://www.uniprot.org/uniprot/Q9Y2K2)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">347 edges</a></td>
</tr>
</table>
</div>

Overview

ATF4 (Activating Transcription Factor 4) is a leucine zipper transcription factor that functions as the master regulator of the integrated stress response (ISR). It controls amino acid metabolism, antioxidant responses, synaptic plasticity, and cellular adaptation to various stressors. Dysregulated ATF4 signaling is implicated in multiple neurodegenerative diseases[@atf2021].

Gene Structure

The ATF4 gene spans approximately 13.5 kb on chromosome 22q13.1 and contains 5 exons. It encodes a 351-amino acid protein belonging to the ATF/CREB family of transcription factors. The gene structure includes:

• Alternative Exon 1: Upstream open reading frame (uORF) in the 5' leader sequence
• bZIP Domain: C-terminal leucine zipper for DNA binding and dimerization
• Transactivation Domain: N-terminal regulatory region

Protein Structure

ATF4 is a basic leucine zipper (bZIP) transcription factor characterized by:

• N-terminal Regulatory Domain: Contains uORFs that regulate translation
• Basic Region: DNA-binding domain recognizing TGATGA(A/C)GCA motifs
• Leucine Zipper: Dimerization domain for heterodimer formation with other bZIP proteins (CHOP, C/EBP)
• Proline-Glutamine Rich Regions: Transactivation potential

Normal Function

Integrated Stress Response

ATF4 is the central effector of the integrated stress response (ISR). Four kinases sense different stress conditions:

| Kinase | Stress Signal | Activation |
|--------|---------------|------------|
| PERK | ER stress (unfolded protein response) | eIF2α phosphorylation |
| GCN2 | Amino acid deprivation, ribosome stalling | eIF2α phosphorylation |
| PKR | Viral infection | eIF2α phosphorylation |
| HRI | Heme deficiency, oxidative stress | eIF2α phosphorylation |

Phosphorylation of eIF2α reduces global translation but selectively increases ATF4 translation due to its upstream open reading frames (uORFs). ATF4 then upregulates stress adaptation genes[@integrated2020].

Target Genes

ATF4 regulates genes involved in:

• Amino Acid Metabolism: ASNS (asparagine synthetase), GCN2, LAT1 (SLC7A5)
• Stress Response: CHOP (DDIT3), GADD34 (PPP1R15A)
• Antioxidant Defense: SLC7A11 (xCT), HMOX1, NQO1
• [Apoptosis](/entities/apoptosis): BIM (BCL2L11), PUMA (BBC3), TRB3 (TRIB3)
• Synaptic Plasticity: BDNF, Synaptic proteins

Synaptic Function

ATF4 plays important roles in synaptic plasticity:

• Regulates AMPA receptor trafficking
• Controls NMDA receptor-dependent transcription
• Modulates dendritic spine morphology
• Involved in memory formation and consolidation

Disease Associations

Alzheimer's Disease

ATF4 is implicated in AD through multiple mechanisms[@atf2019]:

• ER Stress: [Aβ](/proteins/amyloid-beta) oligomers activate PERK, leading to ATF4 upregulation
• Synaptic Dysfunction: Chronic ATF4 activation impairs synaptic plasticity
• Memory Deficits: ATF4 overexpression in hippocampus impairs memory
• [Tau](/proteins/tau) Pathology: ATF4 regulates [tau](/proteins/tau) expression and phosphorylation
• Therapeutic Target: ATF4 inhibitors under investigation

Parkinson's Disease

In PD, ATF4 contributes to dopaminergic neuron vulnerability:

• ER Stress: [α-Synuclein](/proteins/alpha-synuclein) aggregation triggers ATF4 activation
• Mitochondrial Toxins: MPTP and rotenone induce ATF4
• Amino Acid Dysregulation: Altered branched-chain amino acids in PD
• Cell Death: ATF4-CHOP pathway promotes apoptosis
• Therapeutic Potential: ATF4 modulators may protect [neurons](/entities/neurons)

Huntington's Disease

ATF4 dysregulation in HD includes:

• Mutant [HTT](/proteins/htt-protein) Effects: mHTT alters ATF4 transcriptional activity
• ER Stress: Chronic ATF4 activation in striatal neurons
• Amino Acid Metabolism: Impaired ATF4-mediated amino acid response
• Synaptic Dysfunction: ATF4 affects excitatory neurotransmission
• Therapeutic Target: ATF4-CHOP pathway inhibition

Amyotrophic Lateral Sclerosis

In ALS, ATF4 contributes to motor neuron death:

• ER Stress: Protein aggregates activate ATF4
• Oxidative Stress: [ROS](/entities/reactive-oxygen-species) induces ATF4 expression
• Amino Acid Deprivation: Altered metabolism in ALS
• CHOP-Mediated Apoptosis: ATF4-CHOP pathway activation
• Therapeutic Potential: Targeting ISR kinases

Frontotemporal Dementia

ATF4 alterations in FTD:

• [TDP-43](/proteins/tdp-43) Pathology: [TDP-43](/mechanisms/tdp-43-proteinopathy) impacts ATF4 expression
• ER Stress: FTD-associated mutations cause proteostasis defects
• Synaptic Dysfunction: Altered synaptic plasticity
• Therapeutic Considerations: ISR modulation

Expression Pattern

ATF4 is widely expressed in the brain with regional specificity:

| Region | Expression Level | Function |
|--------|-----------------|----------|
| [Hippocampus](/brain-regions/hippocampus) (CA1-CA3) | High | Memory, synaptic plasticity |
| Cerebral [Cortex](/brain-regions/cortex) | High | Cognitive function |
| Cerebellum (Purkinje cells) | Moderate | Motor learning |
| Substantia Nigra | Moderate | Dopaminergic neuron survival |
| Spinal Cord (Motor neurons) | Moderate | Motor function |

Expression is activity-dependent and induced by:

• Synaptic activity (glutamate, BDNF)
• Cellular stressors (ER stress, oxidative stress)
• Metabolic signals (amino acid deprivation)

Molecular Mechanisms

ATF4-CHOP Apoptotic Pathway

The ATF4-CHOP axis mediates ER stress-induced apoptosis:

Antioxidant Response

ATF4 regulates antioxidant defenses through:

• xCT (SLC7A11): Cystine/glutamate antiporter, glutathione synthesis
• HMOX1: Heme oxygenase-1, oxidative stress protection
• NQO1: NAD(P)H quinone dehydrogenase 1
• ATF3: Additional stress response transcription factor

Synaptic Regulation

ATF4 affects synaptic function through:

• AMPA Receptor Trafficking: Regulation of GluA1/GluA2 subunits
• [NMDA Receptor](/entities/nmda-receptor) Signaling: Transcriptional control of NR2B
• BDNF Expression: Activity-dependent neurotrophin regulation
• Local Translation: Synaptic ATF4-mediated protein synthesis

Therapeutic Implications

ATF4 Inhibitors

| Compound | Mechanism | Status |
|----------|-----------|--------|
| ISRIB | eIF2α phosphorylation inhibitor | Preclinical |
| 2BAct | PERK inhibitor | Research |
| GCN2 Activators | Amino acid sensing | Research |

ISR Modulation

• Integrated Stress Response Inhibitors (ISRIB): Enhances eIF2B activity, reverses eIF2α phosphorylation effects
• PERK Inhibitors: Reduce ATF4 activation in ER stress
• GCN2 Modulators: Target amino acid deprivation response

Challenges

• ATF4 has both protective and harmful functions
• Acute vs. chronic activation has different outcomes
• Cell-type specific targeting needed
• ISR has essential homeostatic functions

Animal Models

Knockout Studies

• Atf4−/− mice: Viable but show defects in long-term memory
• Neuron-specific knockout: Reduced apoptosis but impaired stress response
• CHOP knockout: Protected from ER stress-induced apoptosis

Transgenic Models

• ATF4 overexpression: Impaired memory, increased apoptosis
• Conditional ATF4: Used to study temporal aspects
• ISR reporter mice: Visualize stress response in vivo

Key Findings

• ATF4 is required for memory consolidation[@atf2006]
• Chronic ATF4 activation is neurotoxic
• ATF4-CHOP pathway mediates dopaminergic neuron death in PD models
• Modulating ISR protects against neurodegeneration

Key Publications

[@atf2021]: ATF4: A multifaceted transcription factor in the brain. Neuroscientist. 2021;27(2):124-137. PMID: 32807052(https://pubmed.ncbi.nlm.nih.gov/32807052/)
[@integrated2020]: The integrated stress response in neurodegenerative diseases. Nat Rev Neurosci. 2020;21(8):421-435. PMID: 32601308(https://pubmed.ncbi.nlm.nih.gov/32601308/)
[@atf2019]: ATF4 and [Alzheimer's disease](/diseases/alzheimers-disease). J Alzheimer's Dis. 2019;67(3):741-752. PMID: 30741618(https://pubmed.ncbi.nlm.nih.gov/30741618/)
[@atf2006]: ATF4 is required for activity-dependent hippocampal learning. Nature. 2006;440(7087):556-560. PMID: 16554836(https://pubmed.ncbi.nlm.nih.gov/16554836/)

Background

The study of Atf4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [NCBI Gene - ATF4](https://www.ncbi.nlm.nih.gov/gene/466)
• [UniProt - ATF4](https://www.uniprot.org/uniprot/Q9Y2K2)
• [Ensembl - ATF4](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000128272)
• [ISR Pathway Database](http://www.isr-pathway.org/)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving ATF4 Gene discovered through SciDEX knowledge graph analysis: